Table 1. Esophageal cancer-survivor demographics by receiving radiation or not.
| Factor | No radiation | Radiation | |||
|---|---|---|---|---|---|
| N | (%) | N | (%) | ||
| Entire cohort | 3,534 | 43 | 4,676 | 57 | |
| Mean age | 65 | 64 | |||
| <40 | 137 | 3.9 | 189 | 4 | |
| 40–49 | 187 | 5.3 | 287 | 6.1 | |
| 50–59 | 778 | 22 | 1,082 | 23.1 | |
| 60–69 | 1,128 | 31.9 | 1,569 | 33.6 | |
| 70–79 | 913 | 25.8 | 1,093 | 23.4 | |
| ≥80 | 391 | 11.1 | 456 | 9.8 | |
| Chemo | |||||
| No | 3,064 | 86.7 | 735 | 15.7 | |
| Yes | 470 | 13.3 | 3,941 | 84.3 | |
| AJCC stage | |||||
| Local | 1,194 | 33.8 | 452 | 9.7 | |
| Regional | 408 | 11.5 | 1,720 | 36.8 | |
| Distant | 148 | 4.2 | 227 | 4.9 | |
| Unknow | 1,784 | 50.5 | 2,277 | 48.7 | |
| Surgery | |||||
| Unperformed | 882 | 25 | 1,953 | 41.8 | |
| Performed | 1,893 | 53.6 | 1,694 | 36.2 | |
| Unknow | 759 | 21.5 | 1,029 | 22 | |
| Year of diagnosis | |||||
| 1973–1999 | 857 | 24.3 | 1,192 | 25.5 | |
| 2000–2013 | 2,677 | 75.7 | 3,484 | 74.5 | |
| Subsite | |||||
| Cervical | 29 | 0.8 | 162 | 3.5 | |
| Upper thoracic | 107 | 3 | 307 | 6.6 | |
| Middle thoracic | 467 | 13.2 | 940 | 20.1 | |
| Lower thoracic | 2,269 | 64.2 | 2,671 | 57.1 | |
| Unknow | 662 | 18.7 | 596 | 12.7 | |
| Race | |||||
| Black | 278 | 7.9 | 567 | 12.1 | |
| Other | 206 | 5.8 | 264 | 5.6 | |
| White | 3,050 | 86.3 | 3,845 | 82.2 | |
| Grade | |||||
| G1 | 388 | 11 | 271 | 5.8 | |
| G2 | 1,145 | 32.4 | 1,703 | 36.4 | |
| G3/G4 | 901 | 25.5 | 1,763 | 37.7 | |
| Unknow | 1,100 | 31.1 | 939 | 20.1 | |
| Sex | |||||
| Female | 813 | 23 | 1,193 | 25.5 | |
| Male | 2,721 | 77 | 3,483 | 74.5 | |
| Histology | |||||
| Adenocarcinoma | 2,281 | 64.5 | 2,182 | 46.7 | |
| Squamous cell | 811 | 22.9 | 2,180 | 46.6 | |
| Other | 442 | 12.5 | 314 | 6.7 | |